Danaher Co. (DHR) Holdings Trimmed by MERIAN GLOBAL INVESTORS UK Ltd
MERIAN GLOBAL INVESTORS UK Ltd trimmed its holdings in Danaher Co. (NYSE:DHR) by 99.2% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 9,400 shares of the conglomerate’s stock after selling 1,132,502 shares during the quarter. MERIAN GLOBAL INVESTORS UK Ltd’s holdings in Danaher were worth $1,021,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. CIBC World Markets Inc. boosted its position in shares of Danaher by 12.5% during the 1st quarter. CIBC World Markets Inc. now owns 22,562 shares of the conglomerate’s stock valued at $2,209,000 after acquiring an additional 2,510 shares during the last quarter. Summit Trail Advisors LLC boosted its position in shares of Danaher by 7,386.7% during the 1st quarter. Summit Trail Advisors LLC now owns 268,623 shares of the conglomerate’s stock valued at $269,000 after acquiring an additional 265,035 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Danaher by 2.2% during the 1st quarter. Principal Financial Group Inc. now owns 1,915,209 shares of the conglomerate’s stock valued at $187,519,000 after acquiring an additional 40,320 shares during the last quarter. Dynamic Technology Lab Private Ltd boosted its position in shares of Danaher by 75.5% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 11,205 shares of the conglomerate’s stock valued at $1,097,000 after acquiring an additional 4,820 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC bought a new position in shares of Danaher during the 1st quarter valued at approximately $103,000. Institutional investors and hedge funds own 77.11% of the company’s stock.
In related news, CFO Daniel L. Comas sold 77,407 shares of the stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $103.93, for a total transaction of $8,044,909.51. Following the sale, the chief financial officer now owns 135,218 shares in the company, valued at approximately $14,053,206.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP William K. Daniel sold 103,086 shares of the stock in a transaction on Friday, August 10th. The shares were sold at an average price of $100.63, for a total value of $10,373,544.18. Following the sale, the executive vice president now owns 167,080 shares in the company, valued at approximately $16,813,260.40. The disclosure for this sale can be found here. Insiders have sold a total of 299,961 shares of company stock worth $30,619,691 in the last 90 days. 11.90% of the stock is currently owned by insiders.
NYSE:DHR opened at $100.39 on Monday. Danaher Co. has a fifty-two week low of $90.05 and a fifty-two week high of $110.13. The firm has a market cap of $70.36 billion, a P/E ratio of 22.66, a P/E/G ratio of 1.93 and a beta of 1.01. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 1.53.
Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The company had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the prior year, the firm posted $1.00 EPS. Danaher’s quarterly revenue was up 7.2% compared to the same quarter last year. Sell-side analysts forecast that Danaher Co. will post 4.51 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.64%. Danaher’s payout ratio is presently 15.88%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: Do stock splits help investors?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.